TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain

被引：0
|
作者：
Dedic, Nina [1 ]
Jones, Philip G. [1 ]
Hajos-Korcsok, Eva [1 ]
Synan, Colleen [1 ]
Wu, Serena [2 ]
Anacker, Christoph [2 ]
Vickers, Steve P. [3 ]
Hecksher-Sorensen, Jacob [4 ]
Zeni, Courtney [1 ]
Milanovic, Snezana [1 ]
Hopkins, Seth C. [1 ]
Bristow, Linda J. [1 ]
Koblan, Kenneth S. [1 ]
机构：
[1] Sunovion Pharmaceut, Marlborough, MA USA
[2] Columbia Univ, Dept Psychiat, New York State Psychiat Inst NYPSI, New York, NY USA
[3] SygnatureDiscovery, Nottingham, England
[4] Gubra ApS, Horsholm, Denmark
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923002079
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [1] TAAR1 Agonist Ulotaront Improves Glycemic Control, Reduces Body Weight and Modulates Neurocircuits Governing Energy Balance and Feeding in Rodents
    Dedic, Nina
    Hajos-Korcsok, Eva
    Jones, Phil G.
    Synan, Colleen
    Wu, Serena
    Anacker, Christoph
    Vickers, Steven P.
    Hecksher-Sorensen, Jacob
    Milanovic, Snezana
    Bristow, Linda J.
    Koblan, Kenneth S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 166 - 166
  • [2] TAAR1 Agonist Ulotaront Improves Glycemic Control, Reduces Body Weight and Modulates Neurocircuits Governing Energy Balance and Feeding in Rodents
    Dedic, Nina
    Hajos-Korcsok, Eva
    Jones, Phil G.
    Synan, Colleen
    Wu, Serena
    Anacker, Christoph
    Vickers, Steven P.
    Hecksher-Sorensen, Jacob
    Milanovic, Snezana
    Bristow, Linda J.
    Koblan, Kenneth S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 166 - 166
  • [3] The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and Type 2 Diabetes
    Daugaard, Jens R.
    Meier, Eddi
    Riber, Ditte
    Baek, Camilla A. E.
    Larsen, Kjeld S.
    Kampen, Gita
    DIABETES, 2010, 59 : A430 - A430
  • [4] SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity
    Ueno, Hikaru
    Ito, Ryo
    Abe, Shin-ichi
    Ookawara, Mitsugi
    Miyashita, Hirohisa
    Ogino, Hitomi
    Miyamoto, Yasufumi
    Yoshihara, Tomoki
    Kobayashi, Akihiro
    Tsujihata, Yoshiyuki
    Takeuchi, Koji
    Watanabe, Masanori
    Yamada, Yukio
    Maekawa, Tsuyoshi
    Nishigaki, Nobuhiro
    Moritoh, Yusuke
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (02): : 172 - 181
  • [5] TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
    Dedic, Nina
    Wang, Lien
    Hajos-Korcsok, Eva
    Hecksher-Sorensen, Jacob
    Roostalu, Urmas
    Vickers, Steven P.
    Wu, Serena
    Anacker, Christoph
    Synan, Colleen
    Jones, Philip G.
    Milanovic, Snezana
    Hopkins, Seth C.
    Bristow, Linda J.
    Koblan, Kenneth S.
    MOLECULAR METABOLISM, 2023, 80
  • [6] Insulin detemir improves glycemic control and reduces the risk of weight gain in comparison to NPH insulin in diabetes
    Draeger, E
    Kim, H
    OBESITY RESEARCH, 2004, 12 : A43 - A43
  • [7] A Specific PPAR δ Agonist Induces Body Weight Loss in Rodent Models of Obesity
    Will, S.
    Kubasiak, D.
    Gareski, T.
    Clark, C.
    Muzzi, K.
    Danner, L.
    Artis, D. R.
    Ibrahim, P. N.
    Bollag, G.
    Lin, J. J.
    Saiah, E.
    Vlasuk, G. P.
    Erbe, D. V.
    Tobin, J. F.
    Perreault, M.
    DIABETES, 2009, 58 : A440 - A440
  • [8] SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control More Than That by Fasiglifam in Rat Models of Diabetes and Obesity
    Moritoh, Yusuke
    Ueno, Hikaru
    Ito, Ryo
    Abe, Shin-Ichi
    Miyashita, Hirohisa
    Ogino, Hitomi
    Ookawara, Mitsugi
    Ishimura, Yoshimasa
    Miyamoto, Yasufumi
    Yoshihara, Tomoki
    Tsujihata, Yoshiyuki
    Takeuchi, Koji
    Nishigaki, Nobuhiro
    Yamada, Yukio
    Watanabe, Masanori
    DIABETES, 2019, 68
  • [9] The Novel Long Acting GLP-1/Glucagon Dual Agonist HM12525A Reduces Body Weight and Improves Glycermic Control in Rodent Models
    Jung, Sung Yeob
    Kim, Jin Sun
    Choi, In Young
    Lee, Kyu Hang
    Lee, Young-Mi
    Kim, Young Hoon
    Kang, Jahoon
    Kwon, Se Chang
    DIABETES, 2013, 62 : A268 - A268
  • [10] The Apelin Receptor Agonist Azelaprag Reduces Weight Gain & Improves Body Composition in DIO Mice
    Wang, Yan
    Cochran, Mary
    Portillo, Claudia
    Yan, Shijun
    Banicki, Matthew
    Banicki, Andrew
    Tsai, Chi-Hao
    Guerrero, Gabriel
    Cowdin, Samantha
    Patil, Christopher
    Rebo, Justin
    Hughes, Robert
    Montgomery, Rusty
    Morgen, Eric
    Fortney, Kristen
    Rubin, Paul
    OBESITY, 2024, 32 : 42 - 43
12345